QPS Clinical NL Jan 2026

Greetings!

Welcome to the Monthly QPS Clinical Newsletter

Discover how QPS is shaping the future by advancing oncology trials, learn about QPS' proprietary GLP-1 and IgG assays, and sharing the latest scientific breakthroughs on the QPS blog.

Oncology Drug Development and Clinical Trials

QPS brings proven expertise to oncology drug development, with over 50 Phase I–II studies conducted across Asia, Europe, and the USA. These studies include diverse cancers including breast, lung, head & neck, and prostate. From small molecules to biologics and immunotherapies, our team delivers end-to-end support, from planning and regulatory guidance to seamless trial execution.

With strong global partnerships and innovative recruitment strategies, QPS ensures rapid patient enrollment and access to regions with high cancer incidence. Our experience and resources help sponsors move their oncology candidates efficiently from trial to market.

Partner with QPS today to streamline your Oncology trial from planning to execution.

Explore the Case Study

Performing Two Global Approval Studies in Cancer Patients

QPS Proprietary GLP-1 and IgG Assays

GLP-1 receptor agonists are now among the fastest-growing therapeutic classes, with semaglutide supporting an expanding range of clinical programs. Our lab offers a proprietary semaglutide assay designed for accurate, reproducible bioanalysis across development stages.

Accurate pharmacokinetic profiling of monoclonal antibodies via LC-MS/MS bioanalysis is critical for dose selection and safety assessment. Our proprietary IgG 1 and IgG 4 assays deliver robust quantification across the full PK curve, supporting accurate exposure assessment.

Browse the QPS Assay Finder

Discover the Future of Science on the QPS Blog

Defying Gravity, Defending Health: Keeping Space Travel Healthy

NASA’s 10 new astronaut candidates were announced in September, following a highly competitive selection process involving more than 8,000 applicants. After completing their training,…

Health Implications of Going to Space

Clinical Services at QPS

When Old Diseases Roar Back: Understanding Diphtheria’s Resurgence

Diphtheria is a preventable bacterial disease that causes a thick membrane to form in the back of the throat, making swallowing and breathing difficult….

A Strain on a Fractured System

Early Phase Clinical Trials

Subscribe to the QPS Blog

Contact the Experts at QPS

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today.

Contact QPS Today

Visit our website www.qps.com

or contact us at infopr@qps.com

for an appointment.

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)